Clinical Trial

Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention

Study acronym: ApoB-guidedLLT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter randomized trial is designed to assess the efficacy of lipid-lowering therapy in patients undergoing percutaneous coronary intervention, comparing an Apolipoprotein B-targeted approach with a Low-Density Lipoprotein Cholesterol (LDL-C)-targeted approach. The primary outcomes are to evaluate the proportion of patients achieving lipid-lowering treatment goals at the 1-year follow-up between the two treatment strategies: Apolipoprotein B-based therapy versus LDL-C-based therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-01.
Trial Details
NCT Number NCT06626126
Lead Sponsor University Medical Center Ho Chi Minh City (UMC)
Collaborators: University of Medicine and Pharmacy at Ho Chi Minh City
Conditions Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention, LDL-cholesterol, Lipid Metabolism Disorders
Enrollment 1,448 participants
Start Date 2025-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-16